Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1315.0000 -55.40 (-4.04%)

NSE Jan 23, 2026 15:31 PM

New 52W Low today

Volume: 6.6M

High volume today

Cipla Ltd.

31 Oct 2024

1315.00

-4.04%

Cipla (HOLD): Conditional launch of gAbraxane likely in FY25

Hold: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Goa plant receiving VAI likely to speed up gAbraxane launch in FY25E. In its 2QFY25 earnings call CIPLA said this would be delayed to H1FY27

Cipla Ltd. is trading at high day volume of 6.6M.